1 |
Ajazuddin, and Saraf, S. (2010). Applications of novel drug delivery system for herbal formulations. Fitoterapia 81, 680-689.
DOI
ScienceOn
|
2 |
Arvizo, R., Bhattacharya, R., and Mukherjee, P. (2010). Gold nanoparticles: opportunities and challenges in nanomedicine. Expert Opin. Drug Deliv. 7, 753-763.
DOI
ScienceOn
|
3 |
Bhadoriya, S.S., Mangal, A., Madoriya, N., and Dixit, P. (2011). Bioavailability and bioactivity enhancement of herbal drugs by "Nanotechnology": a review. J. Curr. Pharmaceutical. Res. 8, 1-7.
|
4 |
Bhattacharyya, S.S., Paul, S., De, A., Das, D., Samadder, A., Boujedaini, N., and Khuda-Bukhsh, A.R. (2011). Poly (lactideco- glycolide) acid nanoencapsulation of a synthetic coumarin: Cytotoxicity and bio-distribution in mice, in cancer cell line and interaction with calf thymus DNA as target. Toxicol. Appl. Pharmacol. 253, 270-282.
DOI
ScienceOn
|
5 |
Bishayee, K., Ghosh, S., Mukherjee, A., Sadhukhan, R., Mondal, J., and Khuda-Bukhsh, A.R. (2013a). Quercetin induces cytochrome c release and ROS accumulation to promote apoptosis and arrest the cell cycle in G2/M, in cervical carcinoma: signal cascade and drug-DNA interaction. Cell Prolif. 46, 153-163.
DOI
ScienceOn
|
6 |
Bishayee, K., Paul, A., Ghosh, S., Sikdar, S., Mukherjee, A., Biswas, R., Boujedaini, N., and Khuda-Bukhsh, A.R. (2013b). Condurango-glycoside-A fraction of Gonolobus condurango induces DNA damage associated senescence and apoptosis via ROS-dependent p53 signalling pathway in HeLa cells. Mol. Cell. Biochem. 382, 173-183.
DOI
ScienceOn
|
7 |
Brannon-Peppas, L., and Blanchette, O.J. (2004). Nanoparticle and targeted systems for cancer therapy. Adv. Drug Deliv. Rev. 56, 1649-1659.
DOI
ScienceOn
|
8 |
Daugaard, M., Nitsch, R., Razaghi, B., McDonald, L., Jarrar, A., Torrino, S., Castillo-Lluva, S., Rotblat, B., Li, L., Malliri, A., et al. (2013). Hace1 controls ROS generation of vertebrate Rac1- dependent NADPH oxidase complexes. Nat. Commun. 4, 2180
|
9 |
Duan, H., Heckman, C.A., and Boxer, L.M. (2005). Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas. Mol. Cell. Biol. 25, 1608-1619.
DOI
ScienceOn
|
10 |
Falkenberg, K.J., and Johnstone, R.W. (2014). Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders. Nat. Rev. Drug Discov. 13, 673-691.
DOI
ScienceOn
|
11 |
Hanahan, D., and Weinberg, R.A. (2011). Hallmarks of cancer: the next generation. Cell 144, 646-674.
DOI
ScienceOn
|
12 |
Fulda, S., and Debatin, K.M. (2006). Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25, 4798-4811.
DOI
ScienceOn
|
13 |
Ghosh, S., Bishayee, K., and Khuda-Bukhsh, A.R. (2014). graveoline isolated from ethanolic extract of ruta graveolens triggers apoptosis and autophagy in skin melanoma cells: a novel apoptosis-independent autophagic signaling pathway. Phytother. Res. 28, 1153-1162
DOI
ScienceOn
|
14 |
Hagelkruys, A., Sawicka, A., Rennmayr, M., and Seiser, C. (2011). The biology of HDAC in cancer: the nuclear and epigenetic components. Handb. Exp. Pharmacol. 206, 13-37.
DOI
|
15 |
Harper, J.W., Adami, G.R., Wei, N., Keyomarsi, K., and Elledge, S.J. (1993). The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 75, 805-816.
DOI
ScienceOn
|
16 |
Havsteen, B. (2002). The biochemistry and medical significance of the flavonoids. Pharmacol. Ther. 6, 67-202.
DOI
ScienceOn
|
17 |
Huang, B.H., Laban, M., Leung, C.H., Lee, L., Lee, C.K., and Salto- Tellez, M. (2005). Inhibition of histone deacetylase 2 increases apoptosis and p21Cip1/WAF1 expression, independent of histone deacetylase 1. Cell Death Differ. 12, 395-404.
DOI
ScienceOn
|
18 |
Hurley, L.H. (2002). DNA and its associated processes as targets for cancer therapy. Nat. Rev. Cancer 2, 188-200.
DOI
ScienceOn
|
19 |
Jain, S., Hirst, D.G., and O'Sullivan, J.M. (2012). Gold nanoparticles as novel agents for cancer therapy. Br. J. Radiol. 85, 101-113.
DOI
ScienceOn
|
20 |
Karbowski, M., and Youle, R.J. (2003). Dynamics of mitochondrial morphology in healthy cells and during apoptosis. Cell Death Differ. 10, 870-880.
DOI
ScienceOn
|
21 |
Kim, M.J., Sun, Y., Yang, H., Kim, N.H., Jeon, S.H., and Huh, SO. (2012). Involvement of the cAMP response element binding protein, CREB, and cyclin D1 in LPA-induced proliferation of P19 embryonic carcinoma cells. Mol. Cells 34, 323-328.
DOI
|
22 |
Kumari, A., Yadav, S.K., and Yadav, S.C. (2010). Biodegradable polymeric nanoparticles based drug delivery systems. Colloid. Surfaces. B. 75, 1-18.
DOI
ScienceOn
|
23 |
Lee, H., and Odom, T.W. (2015). Controlling ligand density on nanoparticles as a means to enhance biological activity. Nanomedicine 10, 177-180.
DOI
ScienceOn
|
24 |
Lemarie, A., and Grimm, S. (2011). Mitochondrial respiratory chain complexes: apoptosis sensors mutated in cancer. Oncogene 300, 3985-4003.
|
25 |
Liu, S. (2012). Epigenetics advancing personalied nanomedicine in cancer therapy. Adv. Drug Deliv. Rev. 64, 1532-1543.
DOI
ScienceOn
|
26 |
Loo, D.T. (2002). TUNEL Assay: An Overview of Techniques. In in situ detection of DNA damage: methods and protocol, Didenko, V.V. eds. (Spinger), pp. 313-323.
|
27 |
Maitland, M.L., and Schilsky, R.L. (2011). Clinical trials in the era of personalized oncology. CA Cancer J. Clin. 61, 365-381.
DOI
|
28 |
Marks, P.A., Richon, V.M., and Rifkind, R.A. (2000). Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J. Natl. Cancer Inst. 92, 1210-1216.
DOI
ScienceOn
|
29 |
Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-63.
DOI
ScienceOn
|
30 |
Mikhailov, V., Mikhailova, M., Pulkrabek, D.J., Dong, Z., Venkatachalam, M.A., and Saikumar, P. (2001). Bcl-2 prevents Bax oligomerization in the mitochondrial outer membrane. J. Biol. Chem. 276, 18361-18374.
DOI
ScienceOn
|
31 |
Noh, J.H., Jung, K.H., Kim, J.K., Eun, J.W., Bae, H.J., and Xie, H.J. (2011). Aberrant regulation of HDAC2 mediates proliferation of hepatocellular carcinoma cells by deregulating expression of G1/S cell cycle proteins. PLoS One 6, e28103.
DOI
ScienceOn
|
32 |
Puhl, A.C., Fagundes, M., dos Santos, K.C., Polikarpov, I., das Gracas, M.F., da Silva, F., Fernandes, J.B., Vieira, P.C., and Forim, M.R. (2011). Preparation and characterization of polymeric nanoparticles loaded with the flavonoid luteolin, by using factorial design. Int. J. Drug Deliv. 3, 683-698.
|
33 |
Shahabuddin, M.S., Gopal, M., and Raghavan, S.C. (2009). Intercalating cytotoxic, anti-tumour activity of 8-chloro and 4- morp96holinopyrimido [4',5':4.5]thieno(2,3-b)quinolone. J. Photochem. Photobiol. B. 94, 13-19.
DOI
ScienceOn
|
34 |
Shahbazian, D., Sznol, J., and Kluger, H.M. (2012). Vertical pathway targeting in cancer therapy. Adv. Pharmacol. 65, 1-26.
DOI
ScienceOn
|
35 |
Shobha Devi, C., Anil Kumar, D., Singh, S.S., Gabra, N., Deepika, N., Kumar, Y.P., and Satyanarayana, S. (2013). Synthesis, interaction with DNA, cytotoxicity, cell cycle arrest and apoptotic inducing properties of ruthenium(II) molecular "light switch" complexes. Eur. J. Med. Chem. 64, 410-421.
DOI
ScienceOn
|
36 |
Yu, T., Robotham, J.L., and Yoon, Y. (2006). Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology. Proc. Natl. Acad. Sci. USA 103, 2653-2658.
DOI
ScienceOn
|
37 |
Talluri, S., and Dick, F.A. (2012). Regulation of transcription and chromatin structure by pRB. Cell Cycle 11, 3189-3198.
DOI
|
38 |
Vijayababu, M.R., Kanagaraj, P., Arunkumar, A., Ilangovan, R., Dharmarajan, A., and Arunakaran, J. (2006). Quercetin induces p53-independent apoptosis in human prostate cancer cells by modulating Bcl-2-related proteins: a possible mediation by IGFBP-3. Oncol. Res. 16, 67-74.
DOI
|